Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease. by Tran, Wen-Ching et al.
UCSF
UC San Francisco Previously Published Works
Title
Understanding barriers to medication, dietary, and lifestyle treatments prescribed in 
polycystic kidney disease.
Permalink
https://escholarship.org/uc/item/23d8n36p
Journal
BMC nephrology, 18(1)
ISSN
1471-2369
Authors
Tran, Wen-Ching
Huynh, David
Chan, Tea
et al.
Publication Date
2017-07-05
DOI
10.1186/s12882-017-0641-3
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
RESEARCH ARTICLE Open Access
Understanding barriers to medication,
dietary, and lifestyle treatments prescribed
in polycystic kidney disease
Wen-Ching Tran1, David Huynh2, Tea Chan2, Catherine A. Chesla3 and Meyeon Park2*
Abstract
Background: Autosomal dominant polycystic kidney disease (PKD) is the most common genetic renal disease and
the fourth leading cause of end-stage renal disease in the United States. Although there is no cure for PKD, several
treatments are considered to be beneficial, including blood pressure control, exercise, low-salt diet, and high
volume water intake. However, levels of understanding of the importance of these treatments and adherence to
these recommendations vary among patients. This study explores illness perception models of patients with PKD to
reveal barriers in adherence to prescribed therapies; satisfaction with medical care; and sources of medical
information.
Methods: We designed a phenomenological interview study to evaluate illness perception models of individuals
with PKD. Patients were identified from the national PKD Foundation e-mail distribution list (N = 190) and
responded voluntarily to an introductory survey (N = 50). Seventeen PKD patients in the Bay Area were scheduled
for one-on-one in-depth interviews with one trained interviewer (W-CT). Open-ended questions administered with
an interview guide were used to evaluate patients’ beliefs.
Results: Mean age was 56.6 +/− 12 years (range 29–78); 65% were female. Many of the PKD patients in this study
were highly motivated and willing to incorporate blood pressure, exercise, low-salt diet, and high volume water
intake into their daily routines. Barriers to adherence to these therapies include personal beliefs and confusion due
to unclear recommendations.
Conclusions: These findings suggest there is variability between what patients understand about their disease and
treatments and what they believe their doctors have told them. Not all physicians focus on lifestyle-based
treatments, but the majority of PKD patients in our study are motivated and willing to incorporate blood pressure
control, exercise, low-salt diet, and high volume water intake into their daily routines and would like specific
recommendations on how to implement these. These findings support a role for further exploring patient beliefs
about the disease and its necessary treatments in order to design strategies to improve communication and meet
the needs of these patients.
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Background
Autosomal dominant polycystic kidney disease (PKD) is
the most common genetic renal disease and the fourth
leading cause of end-stage kidney disease in the United
States [1]. Individuals with PKD have a high risk of
hypertension and cardiovascular disease, independent of
renal function [2]. Currently, there is no cure for PKD.
Consequently, many individuals experience a high de-
gree of emotional distress from this disease, and uncer-
tainty about disease progression is a major source of
distress [3]. The inability to influence disease progres-
sion is a major source of feelings of helplessness and
hopelessness in these patients [3].
Despite the absence of a cure, several recommended
treatments may attenuate progression of kidney disease
and / or reduce risk of cardiovascular events. These in-
clude 1) blood pressure control [4]; 2) exercise [5]; 3)
low-salt diet [6]; and 4) high volume water intake [7].
The recently published HALT-PKD trial [4] demon-
strated that in individuals with preserved renal function,
using an angiotensin converting enzyme inhibitor (ACE-
I) to a target systolic blood pressure of less than
110 mmHg is beneficial for several meaningful renal and
cardiovascular outcomes [4]. Adherence to blood pres-
sure medication is notoriously low [8], and to our know-
ledge, adherence specifically in the PKD population has
not been studied. Additionally, while aerobic exercise
has been shown to be beneficial in the general popula-
tion with hypertension [5], it is uncertain how many
PKD patients perform the daily physical activity recom-
mended for the general adult population [9]. As PKD
can cause major pain and discomfort due to enlargement
of kidneys and hemorrhage of cysts, some patients actu-
ally avoid exercise, either on recommendation of a phys-
ician or based on their own experience. Although the
optimal target is controversial, a low-salt diet has been
shown to be of clear benefit for individuals with hyper-
tension [6]. The extent of patient counseling and adher-
ence to a low-salt diet is unknown in the PKD
community. Finally, a suppression of the antidiuretic
hormone (ADH) with high volume water intake is a
known method to attenuate progression of kidney cyst
growth [10, 11], and the medication tolvaptan (an ADH
antagonist) is currently an approved therapy for PKD in
Japan, Canada, and Europe. Although many individuals
are told to “drink a lot of water” to achieve this effect
[7], adherence with this prescription is uncertain.
Levels of understanding of the importance of these
treatments and adherence to these recommendations may
vary among patients. Illness models have been used in the
study of hypertension and other chronic diseases to study
barriers to adherence [12]. The study of illness perception
models has revealed that health-related behavior is
strongly influenced by ideas around five components, or
illness representations. These include cause, nature (includ-
ing seriousness), and treatment of the disease (including
hoped for outcomes from those treatments) [13, 14]. An
understanding of these beliefs is the first step toward de-
signing meaningful interventions to improve adherence to
treatment. This study explores illness perception models,
focusing most centrally on patients perceptions of treat-
ments needed among patients with PKD to reveal barriers
to adherence to prescribed therapies; satisfaction with med-
ical care; and sources of medical information.
Methods
We designed a phenomenological interview study to
evaluate illness perception models of individuals with
PKD [15]. Patients were initially identified from the na-
tional PKD Foundation e-mail distribution list (N = 190)
and voluntarily responded to an introductory survey
(N = 50). Seventeen PKD patients in the Bay Area came
to UCSF for one-on-one in-depth interviews with a
trained interviewer (W-CT). The characteristics of pa-
tients who responded to the survey and the interview
participants are summarized in Table 1. The PKD Foun-
dation does not uniformly collect demographic informa-
tion on members of its e-mail distribution list and thus
information on the individuals who received our survey
is not available. The study was approved by the UCSF
IRB and all participants gave written informed consent.
Interviews were conducted in a private classroom.
Open-ended questions administered with an interview
Table 1 Demographics
Survey respondents
(n= 50)
Interview participants
(n= 17)
Mean Age 55.5 +/− 13.8 years
(Range = 25–89)
56.6 +/− 12 years
(Range = 29–78)
Gender
Female 26 (52%) 11 (64.7%)
Male 21 (42%) 6 (35.3%)
Did not respond 3 (6%) 0
Race/Ethnicity
White, Hispanic or
Latino
7 (14%) 3 (17.6%)
White, not Hispanic
or Latino
31 (62%) 11 (64.7%)
Black 5 (10%) 1 (5.9%)
Asian or Pacific
Islander
4 (8%) 1 (5.9%)
Native American 1 (2%) 0
Prefer not to answer 1 (2%) 1 (5.9%)
Did not respond 1 (2%) 0
Currently on dialysis 3 (6%) 0
Post-kidney transplant 4 (8%) 4 (23.5%)
Tran et al. BMC Nephrology  (2017) 18:214 Page 2 of 7
guide were used to evaluate patient beliefs on 1) the treat-
ments available for PKD; 2) whether they had been pre-
scribed blood pressure control, exercise, low-salt diet, and
high volume water intake and their adherence to these
treatments; and 3) sources of medical information. The
interview guide was developed based on previous studies
conducted by the authors in different patient populations
[16, 17], as well as on personal experience with the
current patient population using guidance from Kvale
[18]. The interview guide followed the elements of the ill-
ness models as recommended by Kleinman [14], but par-
ticular attention was placed on participants beliefs and
practices regarding four established recommendations for
lifestyle change in PKD. The interview guide was drafted
and reviewed by all authors and revised accordingly. Pilot
testing could not be performed due to limited budget,
time for completion of the project, and patient availability.
The full interview guide is provided in Additional file 1.
The sample size was determined by budget, as patients
were remunerated for their time and participation with a
token gift card and reimbursement for parking / transpor-
tation costs.
Each interview was approximately one hour long. The
interviews were audio-recorded without identifiers using
the Voice Recorder app on an iPad. These recordings
were transcribed using rev.com. Transcriptions were
reviewed for quality, and the responses were initially or-
ganized by question on an Excel spreadsheet. The re-
sponses were then coded independently by two trained
individuals (W-CT and DH). Discrepancies were dis-
cussed until consensus was established. The coded data
was grouped into themes [19]. The general framework
for analysis was to note participant’s beliefs about treat-
ments needed, and how these related to PKD self-care
practices. Additionally, we explored how patients came
to believe certain treatments were efficacious, despite
what they had been told. We did not have an a priori
framework for themes. Software was not used to track
coding or facilitate analysis due to budgetary limitations.
No repeat interviews were done for the same reason.
Transcripts and findings were not shared with partici-
pants for comments and/or corrections.
Results
Demographics
Mean age of participants was 56.6 +/− 12 years (range
29–78). Sixty-five percent were female. The majority were
non-Hispanic/Latino Caucasians. None of the participants
were receiving dialysis, while four were post-kidney trans-
plant (Table 1). Many of the PKD patients in this study
were highly motivated and willing to incorporate blood
pressure, exercise, low-salt diet, and high volume water in-
take into their daily routines. Barriers to adherence to
these therapies include personal beliefs and confusion due
to limited recommendations.
Theme 1: Patients motivated by treatment beliefs
Sixteen of the 17 participants reported believing that
blood pressure affects PKD and were also prescribed
blood pressure medication. Of the 16 participants who
were prescribed blood pressure medication, 12 (75%) re-
ported taking his or her medication everyday (Table 2).
Patients felt they “have to” and “need to” take their
Table 2 Summary of Results
Treatment Belief N Recommendations N Adherence N Challenges to Adherence
Blood
pressure
Believes blood
pressure affects PKD
16 Prescribed blood pressure
medication
16 Number of days per week when
remember to take medication:
• Believes diet and exercise
are better than drugs
• Forgets when feeling well
• Forgets when rushed, busy,
or tired
<7 days/week 4
7 days/week 12
Exercise Believes exercise or
physical activity affects
PKD
14 Told to avoid certain types
of exercise or physical
activity
11 Does not adhere to recommendations
to avoid certain exercises of physical
activity
2 • Activity helps mentally
• Disagrees with
recommendations (that
exercise is harmful)
Diet Believes diet affects
PKD
16 Told to follow certain diets 15 Adherence to low-salt diet: • Absence of or conflicting
recommendations
• Affects social aspects of
eating
• Difficult to measure
• By non-physician
sources
10 Does not add salt to food 12
Avoids salty food 4
Does not eat out/
Cooks own meals
4
Water
Intake
Believes drinking a lot
of water affects PKD
10 Told to drink “a lot of
water”
12 Adheres to recommendations 10 • Frequent urination
• Experiences symptoms
• Difficult to develop habit
• By non-physician
sources
3 Does not adhere to recommendations 1
Uncertain 5 Uncertain but tries to adhere to
recommendations
5
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medication every day because “there’s so little that you
can control.” Many participants take extra steps, such as
using pill boxes, leaving the medication at a visible loca-
tion, or having another person provide reminders, to
make sure they take their medications daily.
Similarly, many of the 14 participants who reported
believing exercise and physical activity affects PKD
(Table 2) maintained specific regimens. For example,
several participants reported walking at least 45 min
each day. One participant’s health philosophy was to
“use (his body) or lose it,” so he walked for 45 min about
twice per week, swam for 30 min every other day, and
also did exercises prescribed by his chiropractor. An-
other participant went to a fitness club to use a station-
ary bicycle three times per week and work with a trainer
once a week because “people who are fit…probably do
better than people who lay around on the couch.”
When asked about adherence to low-salt diet, most
believed low-salt diets were of benefit. Fourteen partici-
pants mentioned they do not add salt to food, four said
they avoid salty food, and four did not eat out at restau-
rants and/or cooked their own meals at home (Table 2).
For one individual, maintaining a low salt diet was “life
or death.” She had been placed on the transplant list and
was told by a doctor that she would be on dialysis within
six months. However, she stated, “I lowered my (creatin-
ine) and my BUN and all that, just by diet…and here we
are a little over a year (and I’m) still not on dialysis.”
Participants worked to maintain these diets despite chal-
lenges, including interference with the social aspect of
eating and difficulty measuring the amount of nutrients
consumed. One participant recalled an incident when
she felt ill after a family event because she ate food that
she was advised to avoid “rather than insult them (by re-
fusing).” She explained that she would now “do it differ-
ently…because you’re going to pay the price with your
body.” Another participant had difficulty maintaining
her diet when with friends or traveling because she
would eat out at restaurants more frequently. To avoid
this challenge, she started bringing her own snacks be-
cause her thought was “do you want to eat this, or do
you want to go on dialysis?”
Ten participants reported believing that drinking a lot
of water affects PKD, while 5 were uncertain about its
effects (Table 2). Twelve participants received recom-
mendations to drink “a lot of water,” with 3 out of 12 re-
ceiving them from non-physician sources, including
family members and PKD support groups. Ten partici-
pants reported that they adhered to the recommenda-
tions, while five were uncertain about their adherence
but tried to follow the recommendations (Table 2). The
majority of participants did not keep track of their water
intake, but they incorporated strategies, such as using a
bottle or pitcher that they kept filled, to increase water
intake. One participant reported trying to drink three
33-oz bottles of water per day because “it eliminates a
lot of the pain for me” despite the fact that “it’s challen-
ging because you have to pee every 20 minutes.” An-
other individual recalled how after starting on a diet that
required him to drink a lot of water, he had to be hospi-
talized because his “salt level was too low and that I
needed to stop drinking so much water.”
Theme 2: Personal beliefs contrasting with treatment
recommendations
Patient beliefs about the efficacy and appropriateness of
various treatments affected their self-care behavior. For
the four participants who reported taking medication
fewer than 7 days per week, one challenge with adhering
to the medication regimen was the belief that diet and
exercise were more effective than medications (Table 2).
One participant had taken blood pressure medication
for over 20 years until he started seeing a chiropractor,
who focused him on changes in diet and exercise. He ex-
plained, “I had some hypertension, and now I don’t have
hypertension. Now I changed my diet and changed my
exercise, so somehow I perceive that’s better than the
drugs.”
Some patients became motivated to take their me-
dication when they believed, from personal experience,
reading, or being told by others, that medication is im-
portant for blood pressure control. For example, one
participant realized “I needed to stick to the medica-
tion” because “even though I was really trying to do
everything (in terms of exercise and diet) to keep my
blood pressure down, there was really nothing I could
do (to lower blood pressure).” In another case, the partici-
pant explained, “I was told I have to take my blood pres-
sure medication and all that, I thought, I really don’t. My
dad [who has PKD] is fine…When I started educating my-
self…is when I went…“You should at least take the lisino-
pril because you know your blood pressure is high.”
Similarly, another participant initially believed that she
could lower her blood pressure with exercise. She became
more willing to take her blood pressure medication when
a doctor “had mentioned...that I don’t have (the type of)
kidney disease where your blood pressure can be lowered
because of diet or exercise.”
Eleven participants had been told to avoid certain
types of exercise or physical activity, including contact
sports and weight lifting. Two participants reported de-
liberately going against these recommendations because
the activity helped them psychologically and they had
not experienced any adverse effects (Table 2). One par-
ticipant’s doctor told her to avoid weight lifting, but she
continued to do so because “it helps me mentally” and “I
don't have any side effects from it at all.” She further ex-
plained, “[My doctor] just thinks I’m too extreme…I feel
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like it’s my sanity. Until it makes a difference for me, I
don’t see it as a problem.” Similarly, despite being told
to not lift anything over 25 lb, another participant ad-
mitted, “I do probably lift sometimes 40 pounds, but I
don’t do anything that I feel I’m straining myself…I
think the healthier you are and more fit you are, that
you’re going to probably feel better.”
Theme 3: Confusion due to unclear recommendations
Although fifteen participants had been told to follow
certain diets, only 5 out of 15 received these recommen-
dations from their physician. The remainder learned of
dietary restrictions from nutritionists, dieticians, family
members, and articles (Table 2). One individual knew to
maintain a low-salt diet because her mother, who also
had PKD, never added salt to her food. However, her
physicians never told her to follow a certain diet until
“towards the end or closer to my transplant” when “it
took me prompting (my nephrologist) to recommend
(a referral to a dietician).” In retrospect, she now believed
“a dietician maybe would be a good thing” because it
would have been really helpful to know “sodium levels in
food…what I could look for.” Another participant
expressed a desire to know more from her physician about
“dietary recommendations and lifestyle changes that could
help her kidneys, instead of just ordering labs and saying,
‘Your labs look good. See you next year.’”
Many participants also reported receiving confusing or
conflicting dietary recommendations. One participant
recalled that her nutritionist would recommend “a portion,”
which she found unhelpful because “what is a portion?”
Consequently, she had done reading and used the internet
for dietary recommendations. To add to the confusion, one
participant recalled being referred to a program for kidney
disease patients that included classes on how to eat. How-
ever, she later learned at PKD meetings that “diet care just
for kidney failure is different than kidney failure from PKD”
and there are “a lot of different things that (PKD patients)
are not supposed to have.”
Another participant summarized the challenge of hav-
ing uncertain recommendations: “The hardest part is be-
cause you don’t know that any of it is actually beneficial.
So part of you could just be like, screw it, I’ll just drink
coffee everyday and have steak and hamburgers for din-
ner…Or I could be like, well it might be making my kid-
neys worse, so I’m going to limit everything and suffer a
little bit now in hopes that maybe I’ll prolong the demise
from this disease.”
Several participants received conflicting information
about water intake. One participant recalled, “I’ve been
told to drink a lot of water or you can drink too much
water and it’s going to be a bad thing for you.” She ex-
plained that her doctor always told her to stay hydrated
but “doesn’t tell me what to drink.” On the other hand,
she had heard at research meetings and support groups
that “there’s been studies that show if you drink this much
water that it will help keep you function at a steady pace.”
Because “they just contradict themselves,” she “just drinks
the recommended dose for any given person.”
Similarly, another participant had read a study about
drinking six to eight liters of water per day instead of
two to three liters per day. When she mentioned this to
her first nephrologist, she was told, “It does sound like a
good idea.” When she switched nephrologists, the new
one told her, “That study was inconclusive…drink your
two liters of water a day and don’t worry about drinking
any more.” As a result, the participant reported feeling
“kind of left just blank like I don’t know.” Another indi-
vidual reported that he “read there’s no evidence that
(drinking a lot of water is beneficial).” However, his
nephrologist “believes that it’s the right way to go.”
Discussion
We found that PKD patients are motivated and willing to
incorporate blood pressure control, exercise, low-salt diet,
and high volume water intake into their daily routines.
Seventy-five percent of the participants who were pre-
scribed blood pressure medication reported adherence,
which is higher than the reported 50% medication adher-
ence rates for chronic diseases [15, 16]. Similarly, a majority
of the participants reported adhering to exercise, low-salt
diet, and high volume water intake recommendations. This
is in contrast to generally low adherence rates for lifestyle
changes in hypertension management, with less than 10%
long-term success rates for weight loss and smoking cessa-
tion [15] as well as low rates of achieving desired salt reduc-
tion in clinical trials [17].
The higher adherence rates in this study may be due
to the patients’ beliefs that medication and lifestyle
changes are necessary for slowing the progression of
their disease, as suggested by a patient who believed diet
lowered her creatinine levels and another patient who
became more willing to take her blood pressure medica-
tions after lifestyle changes failed to lower her blood
pressure. This is consistent with the Ross et al. study de-
scribing patients’ beliefs and compliance, which found a
strong correlation between compliance and belief in the
necessity of the intervention [13].
However, personal beliefs can also be a barrier to ad-
herence. Ross et al. also found that individuals who be-
lieved they could control their blood pressure with
lifestyle changes were less likely to be adherent with
their medications [13]. Similarly, the patients in the
study who did not adhere to recommendations reported
personal experiences that went against the recommenda-
tion. For example, one patient in our study did not take
his blood pressure medication as prescribed because he
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believed that exercise and diet were more effective for
blood pressure control.
Another barrier to adherence that we identified was
confusion due to unclear recommendations, especially
about water intake. Many participants reported receiving
conflicting or confusing instructions from physicians or
only receiving recommendations from non-physician
sources. This is consistent with the Bell and Kravitz
study showing that physicians mention the importance
of physical activity/exercise, healthy eating, and sodium
restriction in only 54.2%, 38.3%, and 14.2% of office
visits for hypertension, respectively [20]. This may also
be due to current lack of evidence for best practice for
increasing water intake in various kidney-related diseases
including but not limited to PKD [21]. In a systematic
review of 16 studies investigating high fluid intake and
chronic kidney disease including PKD, recurrent nephro-
lithiasis, and urinary tract infection, interventions ranged
from increasing water intake by 1.5 to 3 l. [21] In the
PKD population, although this may be due to different
targets for water intake recommended at different stages
of kidney disease, most patients in our study did not in-
dicate that they received varying instructions based on
disease stage.
These findings suggest there is variability between
what patients understand about their disease and pre-
scribed treatments and what they believe their doctors
have told them. First, not all physicians focus on
lifestyle-based treatments, but the majority of PKD pa-
tients in our study reported desiring specific recommen-
dations on how to implement these and sought
information from non-physician sources. Many patients
expressed a desire for greater engagement from their ne-
phrologists in addressing modifiable lifestyle choices as
well as greater communication. This echoes the desire
for greater physician contact during the “latent period”
between diagnosis and symptom manifestations ob-
served by Baker et al. in a previous study in England [3].
This also suggests that a multidisciplinary approach in-
cluding dietitians, primary doctors, and other specialists
may be beneficial for PKD patients.
Second, participants experienced confusion about
recommendations, which further supports a need for
improving communication between physicians and pa-
tients. While patients may be receiving varying advice
due to limited evidence or different stages of kidney
disease, these should be made clear to patients. Fur-
thermore, it may be helpful to provide more specific in-
structions given that participants expressed confusion
over vague recommendations. Studies support that pro-
viding specific instructions including the amount and
frequency of water intake (i.e. drink 500 mL of water
three times daily before meals) achieved more consist-
ent changes [21].
This study has strengths and limitations. Our inter-
view strategy allowed participants to freely express their
personal beliefs, whether or not these agreed with phys-
ician recommendations. We used an interview guide but
provided opportunities for participants to discuss their
responses in an open-ended fashion. All interviews were
conducted by a single interviewer who was not known
to the patients prior to the interviews, allowing for im-
partiality. The strength of the qualitative method in this
instance is to learn, from the patient’s perspective, how
beliefs and practices regarding PKD care develop, given
that there are not widely recognized or disseminated
guidelines for how patients should take care of their dis-
ease. Qualitative inquiry is particularly suited to situa-
tions of ambiguity. Because guidelines for self-care in
PKD are ambiguous, and can change over the course of
the disease, patients need to interpret and adapt what
they have heard regarding self-care. The qualitative ap-
proach employed is sensitive to variations in patient be-
liefs and efforts at self-care. Limitations of the study
included the small number of patients represented, and
the fact that all were from the Northern California re-
gion. However, the participants were drawn from many
different nephrology practices and qualitative research
conducted with a rigorous approach generally allows for
a smaller sample size than quantitative research studies.
In addition, the participants voluntarily responded to a
survey sent to the national PKD foundation email list,
which may be selecting for individuals who are more
proactive and motivated to pursue interventions. Those
who are members of the email list may also be more
technologically savvy and/or of higher socioeconomic
status with access to a computer and the Internet, allow-
ing for greater exposure to information and resources.
Although this may limit generalizability, the themes that
emerged from these interviews represent important
areas that warrant further evaluation in the broader
PKD community. We recognize that a deeper explor-
ation in a larger sample may reveal other themes and
sub-themes. The current study also did not allow for
obtaining physician perspectives.
Conclusions
Overall, most PKD patients in our study were highly moti-
vated to pursue therapies they believed to be helpful
whether prescribed by a doctor or another source of infor-
mation. These findings support a role for further exploring
patient beliefs about the disease and its necessary treat-
ments in order to design strategies to improve communi-
cation and meet the needs of these patients. Participants
also experienced some confusion about topics including
lifestyle change, which suggests the need for clarity and
detail especially when prescribing lifestyle modifications.
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